Matt talks to Doug Clinton from Loop Ventures in their Neurotech Podcast Episode 10.

Dr. Matt Angle is the CEO and founder of Paradromics, a brain-computer interface company developing high-bandwidth implantable neural interfaces. Matt completed his B.S. in Biology at Carnegie Melon University and his Ph.D. in Neuroscience at the Max Planck Institute.

Top 3 Takeaways

  1. Paradromics is working on high-density microwire electrode arrays because they’re advantageous in a number of ways as compared to alternative types of invasive neural interfaces.
  2. The technology under development by Paradromics will first be used by researchers to ask and answer basic neuroscience questions, and then will help treat locked-in patients pending further development and FDA approval.
  3. Considerations about neural data privacy are similar to considerations about data privacy in general.